UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

The New England journal of medicine, 2006-12, Vol.355 (23), p.2408-2417

2006

Volltextzugriff (PDF)

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Journal of cancer research and clinical oncology, 2018-05, Vol.144 (5), p.945-954

2018

Volltextzugriff (PDF)

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations

Blood, 2009-12, Vol.114 (24), p.4944-4953

2009

Volltextzugriff (PDF)

Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots

Nature communications, 2016-04, Vol.7 (1), p.11468-11468, Article 11468

2016

Volltextzugriff (PDF)

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia

Blood, 2012-11, Vol.120 (19), p.3898-3905

2012

Volltextzugriff (PDF)

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

Haematologica (Roma), 2024-02, Vol.109 (2), p.401

2024

Volltextzugriff (PDF)

Capillary-Mediated Single-Cell Dispenser

Analytical chemistry (Washington), 2021-08, Vol.93 (31), p.10750-10755

2021

Volltextzugriff (PDF)

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

Journal of clinical oncology, 2009-12, Vol.27 (35), p.6041-6051

2009

Volltextzugriff (PDF)

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia

Leukemia research, 2014-01, Vol.38 (1), p.10-20

2014

Volltextzugriff (PDF)

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS

Blood, 2012-08, Vol.120 (7), p.1398-1408

2012

Volltextzugriff (PDF)

Sequencing small genomic targets with high efficiency and extreme accuracy

Nature methods, 2015-05, Vol.12 (5), p.423-425

2015

Volltextzugriff (PDF)

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

Leukemia, 2023-11, Vol.37 (11), p.2150-2167

2023

Volltextzugriff (PDF)

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

PloS one, 2022-01, Vol.17 (3), p.e0265278-e0265278

2022

Volltextzugriff (PDF)

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

Leukemia, 2020-08, Vol.34 (8), p.2064-2073

2020

Volltextzugriff (PDF)

A Fluorescence-Activated Single-Droplet Dispenser for High Accuracy Single-Droplet and Single-Cell Sorting and Dispensing

Analytical chemistry (Washington), 2019-05, Vol.91 (10), p.6815-6819

2019

Volltextzugriff (PDF)

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

Science translational medicine, 2013-02, Vol.5 (174), p.174ra27

2013

Volltextzugriff (PDF)

A graphical, interactive and GPU-enabled workflow to process long-read sequencing data

BMC genomics, 2021-08, Vol.22 (1), p.1-626, Article 626

2021

Volltextzugriff (PDF)

MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries

Stem cells (Dayton, Ohio), 2008-10, Vol.26 (10), p.2496-2505

2008

Volltextzugriff (PDF)

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

Leukemia, 2021-05, Vol.35 (5), p.1344-1355

2021

Volltextzugriff (PDF)

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Blood, 2012-03, Vol.119 (11), p.2657-2664

2012

Volltextzugriff (PDF)

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network

Haematologica (Roma), 2023-11, Vol.108 (11), p.3148-3151

2023

Volltextzugriff (PDF)

The Biology of CML blast crisis

Hematology, 2007, Vol.2007 (1), p.384-391

Radich, Jerald P

2007

Volltextzugriff (PDF)

26 – 50 von 571

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(516)
Mit Volltextzugriff
(486)

Publikationsform

Artikel
(558)
Buchkapitel
(13)

Sprache

Englisch
(570)
Japanisch
(61)
Russisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(275)
Humans
(264)
Life Sciences & Biomedicine
(258)
Hematology
(179)
Oncology
(106)
Female
(103)
Male
(100)
Adult
(92)
Biological And Medical Sciences
(88)
Middle Aged
(88)
Medical Sciences
(85)
Treatment Outcome
(79)
Hematologic And Hematopoietic Diseases
(76)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(73)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(68)
Aged
(65)
Chronic Myeloid Leukemia
(64)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(62)
Adolescent
(60)
Prognosis
(60)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

Dasatinib treatment of chronic-phase chronic myeloid leukemia: analysis of responses according to preexisting BCR-ABL mutations

Optical painting and fluorescence activated sorting of single adherent cells labelled with photoswitchable Pdots

A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia

Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia

Capillary-Mediated Single-Cell Dispenser

Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

Implications of BCR-ABL1 kinase domain-mediated resistance in chronic myeloid leukemia

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials

Sequencing small genomic targets with high efficiency and extreme accuracy

European LeukemiaNet laboratory recommendations for the diagnosis and management of chronic myeloid leukemia

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study

A Fluorescence-Activated Single-Droplet Dispenser for High Accuracy Single-Droplet and Single-Cell Sorting and Dispensing

Transferred WT1-reactive CD8+ T cells can mediate antileukemic activity and persist in post-transplant patients

Nilotinib is effective in patients with chronic myeloid leukemia in chronic phase after imatinib resistance or intolerance: 24-month follow-up results

A graphical, interactive and GPU-enabled workflow to process long-read sequencing data

MicroRNA Discovery and Profiling in Human Embryonic Stem Cells by Deep Sequencing of Small RNA Libraries

Phase III, Randomized, Open-Label Study of Daily Imatinib Mesylate 400 mg Versus 800 mg in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase Using Molecular End Points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial

The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation

Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 acute myeloid leukemia risk stratifications: a report from the SWOG Cancer Research Network

The Biology of CML blast crisis

Suchergebnisse filtern